Human defensins and cytokines in vaginal lavage fluid of women with bacterial vaginosis

International Journal of Gynecology and Obstetrics

Volumn 103, Issue 1, 2008, Pages 50-54

  Fan, S R ^a   Liu, X P ^a   Liao, Q P ^b  

^a PEKING UNIVERSITY SHENZHEN HOSPITAL   (China)

^b PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

Bacterial vaginosis; Human defensin 5; Human defensin 2; Interleukin 4

Indexed keywords

BETA DEFENSIN 2; CYTOKINE; DEFENSIN; DEFENSIN 5; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; VAGINA DISCHARGE; VAGINA FLORA; VAGINAL LAVAGE; VAGINITIS;

EID: 52049124238     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2008.05.020     Document Type: Article

References (25)

1. Amsel R., Totten P.A., Spiegel C.A., Chen K.C., Eschenbach D., and Holmes K.K. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med 74 1 (1983) 14-22
2. Nugent R.P., Krohn M.A., and Hillier S.L. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 29 2 (1991) 297-301
3. Sobel J.D. What's new in bacterial vaginosis and trichomoniasis?. Infect Dis Clin North Am 19 2 (2005) 387-406
4. Bradshaw C.S., Morton A.N., Hocking J., Garland S.M., Morris M.B., Moss L.M., et al. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J Infect Dis 193 11 (2006) 1478-1486
5. Chen H., Xu Z., Peng L., Fang X., Yin X., Xu N., et al. Recent advances in the research and development of human defensins. Peptides 27 4 (2006) 931-940
6. Jenssen H., Hamill P., and Hancock R.E. Peptide antimicrobial agents. Clin Microbiol Rev 19 3 (2006) 491-511
7. Keller M.J., and Herold B.C. Impact of microbicides and sexually transmitted infections on mucosal immunity in the female genital tract. Am J Reprod Immunol 56 5-6 (2006) 356-363
8. Porter E., Yang H., Yavagal S., Preza G.C., Murillo O., Lima H., et al. Distinct defensin profiles in Neisseria gonorrhoeae and Chlamydia trachomatis urethritis reveal novel epithelial cell-neutrophil interactions. Infect Immun 73 8 (2005) 4823-4833
9. Sun L., Finnegan C.M., Kish-Catalone T., Blumenthal R., Garzino-Demo P., La Terra Maggiore G.M., et al. Human beta-defensins suppress human immunodeficiency virus infection: potential role in mucosal protection. J Virol 79 22 (2005) 14318-14329
10. Buck C.B., Day P.M., Thompson C.D., Lubkowski J., Lu W., Lowy D.R., et al. Human alpha-defensins block papillomavirus infection. Proc Natl Acad Sci U S A 103 5 (2006) 1516-1521
11. Hazrati E., Galen B., Lu W., Wang W., Ouyang Y., Keller M.J., et al. Human alpha- and beta-defensins block multiple steps in herpes simplex virus infection. J Immunol 177 12 (2006) 8658-8666
12. Balu R.B., Savitz D.A., Ananth C.V., Hartmann K.E., Miller W.C., Thorp J.M., et al. Bacterial vaginosis and vaginal fluid defensins during pregnancy. Am J Obstet Gynecol 187 5 (2002) 267-271
13. Valore E.V., Wiley D.J., and Ganz T. Reversible deficiency of antimicrobial polypeptides in bacterial vaginosis. Infect Immun 74 10 (2006) 5693-5702
14. Sawada M., Otsuki K., Mitsukawa K., Yakuwa K., Nagatsuka M., and Okai T. Cervical inflammatory cytokines and other markers in the cervical mucus of pregnant women with lower genital tract infection. Int J Gynecol Obstet 92 2 (2006) 117-121
15. Boniotto M., Jordan W.J., Eskdale J., Tossi A., Antcheva N., Crovella S., et al. Human beta-defensin 2 induces a vigorous cytokine response in peripheral blood mononuclear cells. Antimicrob Agents Chemother 50 4 (2006) 1433-1441
16. Cauci S., Guaschino S., Driussi S., De Santo D., Lanzafame P., and Quadrifoglio F. Correlation of local interleukin-8 with immunoglobulin A against Gardnerella vaginalis hemolysin and with prolidase and sialidase levels in women with bacterial vaginosis. J Infect Dis 185 11 (2002) 1614-1620
17. Cauci S., Guaschino S., De Aloysio D., Driussi S., De Santo D., Penacchioni P., et al. Interrelationships of interleukin-8 with interleukin-1beta and neutrophils in vaginal fluid of healthy and bacterial vaginosis positive women. Mol Hum Reprod 9 1 (2003) 53-58
18. Basso B., Giménez F., and López C. IL-1beta, IL-6 and IL-8 levels in gyneco-obstetric infections. Infect Dis Obstet Gynecol 13 4 (2005) 207-211
19. Hedges S.R., Barrientes F., Desmond R.A., and Schwebke J.R. Local and systemic cytokine levels in relation to changes in vaginal flora. J Infect Dis 193 4 (2006) 556-562
20. Tavares-Murta B.M., de Resende A.D., Cunha F.Q., and Murta E.F. Local profile of cytokines and nitric oxide in patients with bacterial vaginosis and cervical intraepithelial neoplasia. Eur J Obstet Gynecol Reprod Biol 138 1 (2008) 93-99
21. Alvarez-Olmos M.I., Barousse M.M., Rajan L., Van Der Pol B.J., Fortenberry D., Orr D., et al. Vaginal lactobacilli in adolescents: presence and relationship to local and systemic immunity, and to bacterial vaginosis. Sex Transm Dis 31 7 (2004) 393-400
22. Yasodhara P., Raghunath M., Sreeramulu D., Venu L., Hemalatha R., and Krishna T.P. Local immunity in Indian women with bacterial vaginosis. J Reprod Immunol 70 1-2 (2006) 33-41
23. Hanna N.F., Taylor-Robinson D., Kalodiki-Karamanoli M., Harris J.R., and McFadyen I.R. The relation between vaginal pH and the microbiological status in vaginitis. Br J Obstet Gynaecol 92 12 (1985) 1267-1271
24. Takeda K., Kishimoto T., and Akira S. STAT6: its role in interleukin 4-mediated biological functions. J Mol Med 75 5 (1997) 317-326
25. Babula O., Lazdāne G., Kroica J., Linhares I.M., Ledger W.J., and Witkin S.S. Frequency of interleukin-4 (IL-4) -589 gene polymorphism and vaginal concentrations of IL-4, nitric oxide, and mannose-binding lectin in women with recurrent vulvovaginal candidiasis. Clin Infect Dis 40 9 (2005) 1258-1262